Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,199.00
-34.00 (-2.76%)
Sep 16, 2026, 1:15 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 112.67 billion as of September 15, 2026. Its market cap has increased by 26.27% in one year.
Market Cap
112.67B
Enterprise Value
149.32B
Revenue
33.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,199.00
ChartMarket Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 112.67B, an increase of 193.43%. That is a compound annual growth rate of 4.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 111.66B | 49.20% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 190.53B |
| Oncolys BioPharma | 188.13B |
| PeptiDream | 136.35B |
| SanBio Company | 70.72B |
| Heartseed | 55.75B |
| 3-D Matrix | 52.09B |
| Cuorips | 47.42B |
| Healios K.K. | 39.02B |